Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Bisphosphonates Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing rate of aging population in economies
5.1.1.2. Rising investments to improve healthcare infrastructure
5.1.1.3. Improving reimbursement policies and healthcare access
5.1.2. Restraints
5.1.2.1. Adverse effects of bisphosphonates
5.1.3. Opportunities
5.1.3.1. Rising number of spine fusion surgeries
5.1.3.2. R&D in the arena of novel drugs development
5.1.4. Challenges
5.1.4.1. Limited awareness and dearth of skilled professionals
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Bisphosphonates Market, by Therapeutic Areas
6.1. Introduction
6.2. Cancer
6.3.1. Breast Cancer
6.3.2. Myeloma
6.3. Degenerative Bone Diseases
6.4.1. Hypocalcemia
6.4.2. Osteoporosis

7. Bisphosphonates Market, by Mode of Delivery
7.1. Introduction
7.2. Intravenous
7.3. Oral

8. Bisphosphonates Market, by Application
8.1. Introduction
8.2. Gynecology
8.3. Oncology
8.4. Orthopedics

9. Bisphosphonates Market, by Distribution Channel
9.1. Introduction
9.2. Hospitals
9.3. Online Channels
9.4. Retail Pharmacies

10. Americas Bisphosphonates Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Bisphosphonates Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Bisphosphonates Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Apotex Inc.
14.1.2. Asahi Kasei Corp.
14.1.3. Dr. Reddy’s Laboratories Ltd.
14.1.4. F. Hoffmann-La Roche Ltd.
14.1.5. Genentech, Inc.
14.1.6. Merck KGaA
14.1.7. Novartis AG
14.1.8. Pfizer Inc.
14.1.9. Sanofi S.A.
14.2. Key Product Portfolio

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing



List of Figures

FIGURE 1. BISPHOSPHONATES MARKET RESEARCH PROCESS
FIGURE 2. BISPHOSPHONATES MARKET SIZE, 2023 VS 2030
FIGURE 3. BISPHOSPHONATES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BISPHOSPHONATES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BISPHOSPHONATES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BISPHOSPHONATES MARKET DYNAMICS
FIGURE 7. BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2030 (%)
FIGURE 8. BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2030 (%)
FIGURE 10. BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. BISPHOSPHONATES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. BISPHOSPHONATES MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. BISPHOSPHONATES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. BISPHOSPHONATES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BISPHOSPHONATES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 6. BISPHOSPHONATES MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 8. BISPHOSPHONATES MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. BISPHOSPHONATES MARKET SIZE, BY MYELOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 12. BISPHOSPHONATES MARKET SIZE, BY HYPOCALCEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. BISPHOSPHONATES MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 15. BISPHOSPHONATES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. BISPHOSPHONATES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. BISPHOSPHONATES MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. BISPHOSPHONATES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. BISPHOSPHONATES MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 22. BISPHOSPHONATES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. BISPHOSPHONATES MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. BISPHOSPHONATES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. CANADA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 45. CANADA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 46. CANADA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 47. CANADA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 48. CANADA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. CANADA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. MEXICO BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 51. MEXICO BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 52. MEXICO BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 53. MEXICO BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 54. MEXICO BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. MEXICO BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 72. AUSTRALIA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. CHINA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 77. CHINA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 78. CHINA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 79. CHINA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 80. CHINA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. CHINA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. INDIA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 83. INDIA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 84. INDIA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 85. INDIA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 86. INDIA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. INDIA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. INDONESIA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 89. INDONESIA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 90. INDONESIA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 91. INDONESIA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. JAPAN BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 95. JAPAN BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 96. JAPAN BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 97. JAPAN BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 98. JAPAN BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. JAPAN BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. MALAYSIA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 101. MALAYSIA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 102. MALAYSIA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 103. MALAYSIA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. PHILIPPINES BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 107. PHILIPPINES BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 108. PHILIPPINES BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 109. PHILIPPINES BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. SINGAPORE BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 113. SINGAPORE BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 114. SINGAPORE BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 115. SINGAPORE BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. SOUTH KOREA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 119. SOUTH KOREA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 120. SOUTH KOREA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 121. SOUTH KOREA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. TAIWAN BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 125. TAIWAN BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 126. TAIWAN BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 127. TAIWAN BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. THAILAND BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 131. THAILAND BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 132. THAILAND BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 133. THAILAND BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 134. THAILAND BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. THAILAND BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. VIETNAM BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 137. VIETNAM BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 138. VIETNAM BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 139. VIETNAM BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 149. DENMARK BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 150. DENMARK BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 151. DENMARK BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 152. DENMARK BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 153. DENMARK BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. DENMARK BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. EGYPT BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 156. EGYPT BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 157. EGYPT BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 158. EGYPT BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 159. EGYPT BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. EGYPT BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. FINLAND BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 162. FINLAND BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 163. FINLAND BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 164. FINLAND BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 165. FINLAND BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. FINLAND BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. FRANCE BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 168. FRANCE BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 169. FRANCE BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 170. FRANCE BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 171. FRANCE BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. FRANCE BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. GERMANY BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 174. GERMANY BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 175. GERMANY BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 176. GERMANY BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 177. GERMANY BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. GERMANY BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 180. ISRAEL BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. ITALY BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 186. ITALY BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 187. ITALY BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 188. ITALY BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 189. ITALY BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. ITALY BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. NETHERLANDS BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 192. NETHERLANDS BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 193. NETHERLANDS BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. NIGERIA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 198. NIGERIA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 199. NIGERIA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 200. NIGERIA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. NORWAY BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 204. NORWAY BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 205. NORWAY BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 206. NORWAY BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 207. NORWAY BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. NORWAY BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. POLAND BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 210. POLAND BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 211. POLAND BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 212. POLAND BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 213. POLAND BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. POLAND BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. QATAR BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 216. QATAR BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 217. QATAR BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 218. QATAR BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 219. QATAR BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. QATAR BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 234. SOUTH AFRICA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 239. SPAIN BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 240. SPAIN BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 241. SPAIN BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 242. SPAIN BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 243. SPAIN BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. SPAIN BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. SWEDEN BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 246. SWEDEN BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. SWITZERLAND BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 252. SWITZERLAND BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 253. SWITZERLAND BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. TURKEY BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 258. TURKEY BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 259. TURKEY BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 260. TURKEY BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 261. TURKEY BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. TURKEY BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
TABLE 270. UNITED KINGDOM BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
TABLE 272. UNITED KINGDOM BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 275. BISPHOSPHONATES MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 276. BISPHOSPHONATES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 277. BISPHOSPHONATES MARKET LICENSE & PRICING